Kronos Bio, Inc.
KRON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 56.6% | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 100% | 100% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -626.7% | -1,903.5% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -874.1% | -1,791.9% | – | – |
| EPS Diluted | -1.43 | -1.95 | -2.3 | -2.72 |
| % Growth | 26.7% | 15.2% | 15.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |